256 related articles for article (PubMed ID: 30015524)
1. The relationship of serum VEGF and sVEGFR-1 levels with vascular involvement in patients with Behçet's disease.
Sertoglu E; Omma A; Yucel C; Colak S; Sandıkcı SC; Ozgurtas T
Scand J Clin Lab Invest; 2018 Oct; 78(6):443-449. PubMed ID: 30015524
[TBL] [Abstract][Full Text] [Related]
2. Determination of serum vascular endothelial growth factor (VEGF) and VEGF receptor levels with VEGF gene polymorphisms in patients with Behçet's uveitis.
Sertoglu E; Yücel Ç; Omma A; Hayran Y; Colak S; Sandıkçı SC; Durukan AH; Ozgurtas T
Adv Clin Exp Med; 2022 Mar; 31(3):231-240. PubMed ID: 34918882
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor levels are increased and associated with disease activity in patients with Behçet's syndrome.
Cekmen M; Evereklioglu C; Er H; Inalöz HS; Doganay S; Türköz Y; Ozerol IH
Int J Dermatol; 2003 Nov; 42(11):870-5. PubMed ID: 14636202
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor and monocyte chemoattractant protein-1 in Behçet's patients with venous thrombosis.
Bozoglu E; Dinc A; Erdem H; Pay S; Simsek I; Kocar IH
Clin Exp Rheumatol; 2005; 23(4 Suppl 38):S42-8. PubMed ID: 16273763
[TBL] [Abstract][Full Text] [Related]
5. The relationship between serum levels of angiogenin, bFGF, VEGF, and ocular involvement in patients with Behçet's disease.
Yalçındağ A; Gedik-Oğuz Y; Yalçındağ FN
Graefes Arch Clin Exp Ophthalmol; 2013 Jul; 251(7):1807-12. PubMed ID: 23553285
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial and basic fibroblast growth factor serum levels in patients with Behçet's disease.
Erdem F; Gündoğdu M; Kiki I; Ali Sari R; Kiziltunç A
Rheumatol Int; 2005 Oct; 25(8):599-603. PubMed ID: 15257411
[TBL] [Abstract][Full Text] [Related]
7. Serum MMP-2 and MMP-9 in patients with Behçet's disease: do their higher levels correlate to vasculo-Behçet's disease associated with aneurysm formation?
Pay S; Abbasov T; Erdem H; Musabak U; Simsek I; Pekel A; Akdogan A; Sengul A; Dinc A
Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S70-5. PubMed ID: 17949555
[TBL] [Abstract][Full Text] [Related]
8. Value of hematological indices versus VEGF as biomarkers of activity in Behçet's disease.
Gheita TA; Sakr BR; Rabea RE; Abd ElHamid SM
Clin Rheumatol; 2019 Aug; 38(8):2201-2210. PubMed ID: 30919148
[TBL] [Abstract][Full Text] [Related]
9. The Evaluation of the Relationship between sTREM-1, VEGF-B, and VEGF Gene Expression Levels with Disease Activity of Behçet's Patients.
Harmanci K; Akan OY; Pirildar T; Ortan P; Ulman C
Dis Markers; 2018; 2018():2649392. PubMed ID: 30420902
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor and its soluble receptors VEGFR-1 and VEGFR-2 in the serum of patients with systemic lupus erythematosus.
Robak E; Sysa-Jedrzejewska A; Robak T
Mediators Inflamm; 2003 Oct; 12(5):293-8. PubMed ID: 14760936
[TBL] [Abstract][Full Text] [Related]
11. Reduced serum vascular endothelial growth factor receptor-2 (sVEGFR-2) and sVEGFR-1 levels in gastric cancer patients.
Kikuchi S; Obata Y; Yagyu K; Lin Y; Nakajima T; Kobayashi O; Kikuichi M; Ushijima R; Kurosawa M; Ueda J
Cancer Sci; 2011 Apr; 102(4):866-9. PubMed ID: 21219538
[TBL] [Abstract][Full Text] [Related]
12. [Assessment of pro- and antiangiogenic factors blood serum concentrations in patients with hormonal inactive adrenal tumors].
Korzeniewska M; Kołomecki K; Stepień H; Naze M; Stepień T; Kuzdak K
Endokrynol Pol; 2005; 56(1):39-44. PubMed ID: 16335673
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor gene polymorphisms and serum levels in Behçet's disease.
Kamoun M; Houman MH; Hamzaoui A; Hamzaoui K
Tissue Antigens; 2008 Dec; 72(6):581-7. PubMed ID: 19054372
[TBL] [Abstract][Full Text] [Related]
14. Circulating vascular endothelial growth factor (VEGF) and its soluble receptor 1 (sVEGFR-1) are associated with inflammation and mortality in incident dialysis patients.
Yuan J; Guo Q; Qureshi AR; Anderstam B; Eriksson M; Heimbürger O; Bárány P; Stenvinkel P; Lindholm B
Nephrol Dial Transplant; 2013 Sep; 28(9):2356-63. PubMed ID: 23828162
[TBL] [Abstract][Full Text] [Related]
15. Serum vascular endothelial growth factor/soluble vascular endothelial growth factor receptor 1 ratio is an independent prognostic marker in pancreatic cancer.
Chang YT; Chang MC; Wei SC; Tien YW; Hsu C; Liang PC; Tsao PN; Jan IS; Wong JM
Pancreas; 2008 Aug; 37(2):145-50. PubMed ID: 18665074
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor and carotid intima-media thickness in patients with Behçet's disease.
Oztürk MA; Unverdi S; Oktar SO; Bukan N; Gülbahar O; Ureten K; Göker B; Haznedaroglu S; Sungur G; Ciftçi TU; Onat AM
Clin Rheumatol; 2008 Aug; 27(8):961-6. PubMed ID: 18204875
[TBL] [Abstract][Full Text] [Related]
17. Circulating VEGF and its soluble receptors sVEGFR-1 and sVEGFR-2 in patients with acute leukemia.
Wierzbowska A; Robak T; Wrzesień-Kuś A; Krawczyńska A; Lech-Marańda E; Urbańska-Ryś H
Eur Cytokine Netw; 2003; 14(3):149-53. PubMed ID: 14656688
[TBL] [Abstract][Full Text] [Related]
18. Impact of type 2 diabetes on the plasma levels of vascular endothelial growth factor and its soluble receptors type 1 and type 2 in patients with peripheral arterial disease.
Wieczór R; Gadomska G; Ruszkowska-Ciastek B; Stankowska K; Budzyński J; Fabisiak J; Suppan K; Pulkowski G; Rość D
J Zhejiang Univ Sci B; 2015 Nov; 16(11):948-56. PubMed ID: 26537213
[TBL] [Abstract][Full Text] [Related]
19. Selected angiogenic factors in plasma of patients with lower limb symptomatic peripheral arterial disease: preliminary report.
Wieczór R; Gadomska G; Góralczyk B; Stankowska K; Budzyński J; Fabisiak J; Suppan K; Pulkowski G; Rość D
Int Angiol; 2015 Dec; 34(6):545-51. PubMed ID: 25394959
[TBL] [Abstract][Full Text] [Related]
20. Serum homocysteine level is higher in Behçet's disease with vascular involvement.
Ateş A; Aydintuğ O; Olmez U; Düzgün N; Duman M
Rheumatol Int; 2005 Jan; 25(1):42-4. PubMed ID: 14586553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
